MYOCARDIAL FIBROSIS
Clinical trials for MYOCARDIAL FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MYOCARDIAL FIBROSIS trials appear
Sign up with your email to follow new studies for MYOCARDIAL FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common heart drug reverse hidden scarring in heart failure?
Disease control Not yet recruitingThis study looks at whether the drug sacubitril/valsartan can reduce scarring in the heart muscle of people with a type of heart failure called HFpEF. Scarring can make heart failure worse, so reducing it might improve outcomes. The study will use MRI scans to measure scarring be…
Matched conditions: MYOCARDIAL FIBROSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
AI health coach aims to reverse silent heart damage
Disease control Not yet recruitingThis study tests a 12-month app-based program with a health coach and wearable device to see if it can reduce scarring in the heart muscle caused by long-term high blood pressure. Researchers will enroll 200 adults aged 40-70 who have an enlarged heart but no history of heart att…
Matched conditions: MYOCARDIAL FIBROSIS
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated May 22, 2026 13:51 UTC